MDT
53
-3
IBM
55
4
AVGO
27
-20
AMP
61
4
PCG
64
2
MAT
55
4
NI
73
3
IPG
45
-4
MNST
57
-2
NKE
21
-2
RCL
74
5
HOG
47
4
ESS
51
4
K
63
3
CRM
40
3
C
60
5
F
59
4
KMI
85
2
XOM
60
3
OMC
55
-3
MDT
53
-3
IBM
55
4
AVGO
27
-20
AMP
61
4
PCG
64
2
MAT
55
4
NI
73
3
IPG
45
-4
MNST
57
-2
NKE
21
-2
RCL
74
5
HOG
47
4
ESS
51
4
K
63
3
CRM
40
3
C
60
5
F
59
4
KMI
85
2
XOM
60
3
OMC
55
-3
Financhill
Back

Jazz Pharmaceuticals PLC 10K Form

Buy
55

JAZZ
Jazz Pharmaceuticals PLC

Last Price:
$139.81
Seasonality Move:
14.47%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-02 10Q JAZZ/Jazz Pharmaceuticals PLC Quarterly
2023-11-08 10Q JAZZ/Jazz Pharmaceuticals PLC Quarterly
2023-08-09 10Q JAZZ/Jazz Pharmaceuticals PLC Quarterly
2023-05-10 10Q JAZZ/Jazz Pharmaceuticals PLC Quarterly
2022-11-09 10Q JAZZ/Jazz Pharmaceuticals PLC Quarterly
2022-08-03 10Q JAZZ/Jazz Pharmaceuticals PLC Quarterly

Receive JAZZ News And Ratings

See the #1 stock for the next 7 days that we like better than JAZZ

JAZZ Financial Statistics

Sales & Book Value

Annual Sales: $4.1B
Cash Flow: $385.3M
Price / Cash Flow: 6.77
Annual Sales: $67.52
Price / Book: 2.11

Profitability

EPS (TTM): 8.79000
Net Income (TTM): $560.1M
Gross Margin: $3.6B
Return on Equity: 14.39%
Return on Assets: 4.8%

Jazz Pharmaceuticals PLC Earnings Forecast

Key Jazz Pharmaceuticals PLC Financial Ratios

  • The Gross Profit Margin over the past 20 years for JAZZ is 89.05%.
  • The Selling, General & Administrative Expenses for JAZZ have been equal to 34.05% of Gross Profit Margin.
  • The Research & Development expenses have been 21.73% of Revenue.
  • The Interest Expense is 42.51% of Operating Income.
  • The Net Earning history of JAZZ is 13.77% of Total Revenues.
  • Per Share Earnings over the last 21 years have been positive in 13 years.

Jazz Pharmaceuticals PLC Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: JAZZ
CUSIP: G50871
Website: jazzpharmaceuticals.com

Debt

Debt-to-Equity Ratio: 1.49
Current Ratio: 4.46
Quick Ratio: 3.57

Price-to-Earnings

Trailing P/E Ratio: 16.42
Forward P/E Ratio: 6.15

JAZZ Technical Analysis vs Fundamental Analysis

Buy
55
Jazz Pharmaceuticals PLC (JAZZ) is a Buy

Is Jazz Pharmaceuticals PLC a Buy or a Sell?